Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunct betamethasone for hospitalized children with community-acquired pneumonia
2021-005097-25Phase 3Completed
- Sponsor
- University Children's Hospital Basel
- Start
- Apr 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in community-acquired pneumonia (CAP) comparing Betamethasone adjunct arm with Placebo adjunct arm (2 arms). Primary endpoints: Time to clinical stability and CAP-related readmission up to 28 days. Started Apr 2022; status: completed.
02
Drugs
betamethasone + dexchlorpheniraminebetamethasone
03
Conditions
community-acquired pneumonia (CAP)
Beyond the preview
Go deeper on 2021-005097-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-005097-25.